PUNE, India March 10 (Reuters) - The CEO of the world's biggest vaccine maker, Serum Institute of India, said the company has bolstered its manufacturing ahead of launches over the next few years of ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
CULVER CITY, Calif.--(BUSINESS WIRE)-- ImmunityBio, Inc. (NASDAQ: IBRX), has signed an exclusive global arrangement with the Serum Institute of India, the world’s largest manufacturer of vaccines by ...
The agreement enables a full tech transfer of the chikungunya vaccine for future supply to low- and middle-income countries. Expanded collaboration provides future co-development opportunities.
Particularly in sub-Saharan Africa, malaria is one of the leading causes of child mortality, killing about half a million children every year. But the arrival of a new vaccine could now save countless ...
Poonawalla at the Serum Institute of India’s headquarters in Pune in March 2021Prarthna Singh for TIME Adar Poonawalla is no stranger to gambles. He owes his multibillion-dollar empire to a series of ...
India's Serum Institute CEO Poonawalla to bid for IPL champions RCB Adar Poonawalla, CEO of vaccine maker Serum Institute of India, said on Thursday he will bid for the Indian Premier League cricket ...
India-based Wockhardt and a subsidiary of the Serum Institute of India inked a deal (PDF) to build a new fill-finish manufacturing plant in Wrexham, North Wales. Financial details as well as specifics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results